After a lucrative IPO in September, Richmond-based BioAge is seeing its biotech fortunes shift with its stock falling over 70 ...
The billionaire recently bought an obesity drug stock that could soar nearly 20% over the next 12 months, according to Wall ...
Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made ...
(Reuters) - Eli Lilly said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in Pleasant ...
A Boulder-based company that is developing a orally-delivered drug for obesity and metabolic disorders just reached $25M in ...
In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the ...
Eli Lilly & Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling ...
The biotech disclosed Friday plans to terminate a Phase 2 study testing azelaprag with tirzepatide for weight loss following ...
They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...
The latest in health news includes Zealand Pharma's obesity drug trial, a record dengue outbreak in the Americas, CervoMed's ...
Eli Lilly, the US pharmaceutical giant that gained widespread attention globally with its weight-loss treatments, plans to ...
Battling obesity requires a shift away from today’s reactive efforts. Enter Robert F. Kennedy Jr., the controversial nominee ...